GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and ...

Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that muzastotug will be highlighted in ...

D organoid models are becoming increasingly important in biological research and drug discovery. However, their use remains difficult to standardize because the workflow is complex, highly sensitive ...

Early clinical proof-of-concept for WEE1 inhibitor APR-1051 in the ongoing ACESOT-1051 trial with two partial responders at first scan in endometrial cancer patients with PPP2R1A mutationClinical team ...

Exelixis (NASDAQ:EXEL) executives and investors spent part of the discussion at a Leerink event focusing on recent renal cell ...

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in the coming years.

Strengthens global IP and supports strategic positioning in the rapidly growing metabolic therapeutics marketRamat Gan, Israel, March 17, 2026 ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Pacific Pines dad Daniel Roseman was diagnosed with cancer in August 2024, initially told he would make a full recovery.